The content on this site is intended for healthcare professionals only
The present and future agenda of SIOG
SIOG 2020: Prostate task force and geriatric oncology during COVID 19
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients
Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel
Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib
2020 updates in treating NTRK fusion cancer
PARP inhibitors for prostate cancer: What oncology PAs should know
APAO: Current initiatives and hopes for the future
How COVID-19 has impacted oncology nursing practice and guidelines
Big data, machine learning and drug discovery in oncology
